Sanofi, GSK, CSL tapped to expand US bird flu vaccine supply
The companies will use the funds to fill vials and pre-filled syringes with stockpiled vaccine ingredients, aimed at raising ...
Sanofi Healthcare Bidders Revising Offers Over Talc Concerns
Bidders for Sanofi’s consumer healthcare unit are revising their offers in part to address concerns around potential ...
Recordati buys rights to rare immune disorder drug from Sanofi for $825 mln
Italian pharma group Recordati said on Friday it would buy from Sanofi the global rights to a drug used to treat cold ...
Exclusive-Thermo Fisher's plant making infant RSV drug breached FDA rules, documents show
The most recent U.S. Food and Drug Administration inspection of Thermo Fisher's Greenville plant in May identified ...
News updates from September 27: Israel says it hit Hizbollah headquarters; Fed’s preferred inflation gauge cools
US consumer sentiment has reached its highest level since April, as Americans become more optimistic about the economy’s prospects. The University of Michigan’s consumer sentiment index registered a ...
New Hampshire Union Leader11d
Sanofi blockbuster drug wins clearance in U.S. for lung disease
Sanofi’s Dupixent has been cleared for a chronic lung disorder in the US, in another milestone for the blockbuster drug after ...
Sanofi-Regeneron's Dupixent wins FDA's nod for 'smoker's lung'
The U.S. Food and Drug Administration has approved Sanofi and Regeneron's blockbuster drug Dupixent for patients with a ...
US FDA approves Sanofi-Regeneron's Dupixent for 'smoker's lung'
The U.S. Food and Drug Administration has approved Sanofi and Regeneron's blockbuster drug Dupixent for patients with a ...
BioSpace11d
Sanofi and Regeneron’s Dupixent Snags First Biologic Approval in COPD
Already approved in six indications, Sanofi and Regeneron can now add chronic obstructive pulmonary disease to the list for their blockbuster injection. Sanofi and Regeneron’s Dupixent is gearing up ...
Reuters14d
Sanofi gets two bids valuing its consumer health unit at about $17 billion, Bloomberg News reports
Sept 24 (Reuters) - Sanofi (SASY.PA), opens new tab has received two separate bids from private equity firms for its consumer health unit, which could be valued at 15 billion euros ($16.74 billion ...
bnnbloomberg14d
Sanofi Gets Binding Bids from CD&R, PAI for Consumer Arm
(Bloomberg) -- Sanofi has received binding offers for its consumer health division from private equity firms Clayton Dubilier ...